John Treace - Aug 23, 2022 Form 4 Insider Report for TREACE MEDICAL CONCEPTS, INC. (TMCI)

Role
Chief Executive Offer, Director, 10%+ Owner
Signature
/s/ Lisa Taylor as Attorney-in-fact for John T. Treace
Stock symbol
TMCI
Transactions as of
Aug 23, 2022
Transactions value $
$533,756
Form type
4
Date filed
8/24/2022, 07:23 PM
Previous filing
Mar 10, 2022
Next filing
Aug 29, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TMCI Common Stock Purchase $524K +28K +0.51% $18.72 5.48M Aug 23, 2022 Direct F1, F2
transaction TMCI Common Stock Purchase $9.63K +509 +0.01% $18.92 5.48M Aug 24, 2022 Direct F2, F3
holding TMCI Common Stock 1.61M Aug 23, 2022 By Spouse F4
holding TMCI Common Stock 1.47M Aug 23, 2022 By Spouse as cotrustee of a trust dated Sept 30, 2020 F4
holding TMCI Common Stock 1.84M Aug 23, 2022 As Trustee of a trust dated Sept 25, 2020 F5
holding TMCI Common Stock 409K Aug 23, 2022 As Co-Trustee of a trust dated July 29, 2021 F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average purchase price. These shares were bought in multiple transactions at prices ranging from $18.28 to $19.01 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote.
F2 Includes 33,875 restricted stock units.
F3 The price reported in Column 4 is a weighted average purchase price. These shares were bought in multiple transactions at prices ranging from $18.88 to $18.99 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote.
F4 The Reporting Person disclaims beneficial ownership of shares held by his wife directly or in trusts for which his wife serves as trustee or co-trustee.
F5 The Reporting Person disclaims beneficial ownership of shares held in trust for which he serves as Trustee or Co-Trustee.